We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MOS:NYSEMosaic Company (The) Analysis

Data as of 2026-06-17 - not real-time

$21.69

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Current market price of $21.69 sits well below the DCF‑derived fair value of $29.68, implying roughly a 24% upside. The stock trades at a sky‑high trailing P/E of 155 but a forward P/E of just 11.8, reflecting a recent earnings dip and expectations of a rebound. Technicals are bearish: price is under the 20‑day SMA ($22.38) and 50‑day SMA ($23.14), RSI is neutral at 44.9, and the MACD histogram is marginally negative, with support around $19.80 and resistance near $24.50. Volatility is elevated at nearly 50% over the past 30 days and the beta of 0.73 suggests modest market sensitivity, while the Fear & Greed Index signals “Extreme Greed,” hinting at potential over‑optimism in broader markets.
Fundamentally, Mosaic delivers a solid 4.06% dividend yield on a modest payout ratio (~6%), yet free cash flow is negative and debt‑to‑equity is elevated at 48%, raising concerns about sustainability. Gross margins are thin (13%) and ROE is low (0.6%), but forward EPS of $1.84 points to improving profitability. The company’s global footprint across North and South America, Asia and Oceania adds geographic diversification but also regulatory and currency exposure. Overall, the stock appears undervalued on a valuation basis, but faces short‑term technical pressure and medium‑term balance‑sheet risks.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below 20‑day and 50‑day SMAs
  • Bearish MACD and marginally negative histogram
  • High 30‑day volatility (~50%)

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Undervalued relative to DCF fair value
  • Attractive dividend yield with low payout ratio
  • Negative free cash flow and elevated debt

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward earnings improvement (forward EPS $1.84)
  • Long‑term demand for fertilizer inputs
  • Significant upside potential versus current price

Key Metrics & Analysis

Financial Health

Revenue Growth14.40%
Profit Margin0.36%
P/E Ratio154.9
ROE0.59%
ROA2.00%
Debt/Equity48.19
P/B Ratio0.6
Op. Cash Flow$886.1M
Free Cash Flow$-289787488

Technical Analysis

TrendBearish
RSI44.9
Support$19.80
Resistance$24.50
MA 20$22.38
MA 50$23.14
MA 200$26.88
MACDBearish
VolumeIncreasing
Fear & Greed Index92.27

Valuation

Fair Value$29.68
Target Price$26.82
Upside/Downside23.66%
GradeUndervalued
TypeValue
Dividend Yield4.06%

Risk Assessment

Beta0.73
Volatility49.39%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.